NO992110L - Syntese av benzo[f]kinoliner - Google Patents

Syntese av benzo[f]kinoliner

Info

Publication number
NO992110L
NO992110L NO992110A NO992110A NO992110L NO 992110 L NO992110 L NO 992110L NO 992110 A NO992110 A NO 992110A NO 992110 A NO992110 A NO 992110A NO 992110 L NO992110 L NO 992110L
Authority
NO
Norway
Prior art keywords
quinolines
benzo
synthesis
pharmaceutical compositions
benzoquinolin
Prior art date
Application number
NO992110A
Other languages
English (en)
Other versions
NO992110D0 (no
Inventor
John Brennan
Christopher W Doecke
Perry C Heath
Lawrence E Patterson
Uko E Udodong
Leland O Weigel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO992110L publication Critical patent/NO992110L/no
Publication of NO992110D0 publication Critical patent/NO992110D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)

Abstract

Det er beskrevet en fremgangsmåte for fremstilling av intermediære stoffer og benzokinolin-3-one farmasøytiske preparater, slike farmasøytiske preparater er effektive til behandling av tilstander som konsekvens av 5 -reduktase.
NO992110A 1996-10-30 1999-04-30 Syntese av benzo[f]kinoliner NO992110D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2786896P 1996-10-30 1996-10-30
PCT/US1997/019229 WO1998018757A1 (en) 1996-10-30 1997-10-27 Synthesis of benzo[f]quinolinones

Publications (2)

Publication Number Publication Date
NO992110L true NO992110L (no) 1999-04-30
NO992110D0 NO992110D0 (no) 1999-04-30

Family

ID=21840234

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992110A NO992110D0 (no) 1996-10-30 1999-04-30 Syntese av benzo[f]kinoliner

Country Status (20)

Country Link
EP (1) EP0839807A1 (no)
JP (1) JP2001504816A (no)
KR (1) KR20000052952A (no)
AR (1) AR011268A1 (no)
AU (1) AU735651B2 (no)
BR (1) BR9712711A (no)
CA (1) CA2270433A1 (no)
CO (1) CO4930266A1 (no)
EA (1) EA199900429A1 (no)
HU (1) HUP9904069A2 (no)
ID (1) ID21978A (no)
IL (1) IL129689A0 (no)
NO (1) NO992110D0 (no)
NZ (1) NZ335512A (no)
PE (1) PE13899A1 (no)
PL (1) PL333303A1 (no)
TR (1) TR199901543T2 (no)
TW (1) TW438752B (no)
WO (1) WO1998018757A1 (no)
ZA (1) ZA979612B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9911356A (pt) * 1998-06-18 2002-06-11 Lilly Co Eli Sìntese de benzo[f]quinolinonas
CA2338298A1 (en) * 1998-07-29 2000-02-10 Merck & Co., Inc. Tricyclic compounds
CN121378044B (zh) * 2025-12-25 2026-04-17 成都艾迪医药技术有限公司 一种3-氰甲基-5-甲基苯甲酰胺的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5239075A (en) * 1991-08-21 1993-08-24 Eli Lilly And Company Process for the preparation of benzo (f) quinolinones
US5574160A (en) * 1994-05-26 1996-11-12 Eli Lilly And Company Syntheis of benzoquinolinones
US5578724A (en) * 1994-09-20 1996-11-26 Eli Lilly And Company Process for preparation of benzo[f]quinolinones
TW450809B (en) * 1995-03-21 2001-08-21 Lilly Co Eli Pharmaceutical compositions for preventing or treating prostatic cancer comprising benzoquinolin-3-one derivatives
US5629007A (en) * 1995-03-21 1997-05-13 Eli Lilly And Company Method of preventing prostatic cancer development
US5635197A (en) * 1995-03-21 1997-06-03 Eli Lilly And Company Treatment and prevention of prostatic cancer metastasis
US5550134A (en) * 1995-05-10 1996-08-27 Eli Lilly And Company Methods for inhibiting bone loss

Also Published As

Publication number Publication date
AU735651B2 (en) 2001-07-12
ID21978A (id) 1999-08-19
AR011268A1 (es) 2000-08-16
IL129689A0 (en) 2000-02-29
HUP9904069A2 (hu) 2000-04-28
NO992110D0 (no) 1999-04-30
AU4917297A (en) 1998-05-22
CA2270433A1 (en) 1998-05-07
CO4930266A1 (es) 2000-06-27
EA199900429A1 (ru) 1999-10-28
WO1998018757A1 (en) 1998-05-07
ZA979612B (en) 1999-04-28
EP0839807A1 (en) 1998-05-06
TW438752B (en) 2001-06-07
TR199901543T2 (xx) 1999-09-21
KR20000052952A (ko) 2000-08-25
PE13899A1 (es) 1999-02-25
JP2001504816A (ja) 2001-04-10
NZ335512A (en) 2001-08-31
BR9712711A (pt) 1999-10-26
PL333303A1 (en) 1999-11-22

Similar Documents

Publication Publication Date Title
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
CA2292965A1 (en) Pyrrolidine derivative hair growth compositions and uses
ATE180776T1 (de) Naphthylverbindungen, zwischenprodukte, zusammensetzungen und methoden
NO992400L (no) Nye substituerte pyrazolderivater
BR9813767A (pt) Processo e composição para tratar glaucoma de glc1a
ES2173480T3 (es) Preparacion de derivados de ciclohexeno carboxilato.
PL323726A1 (en) Novel derivatives of dolastatin, their production and application
HUP0000288A3 (en) Azetidinone derivatives as inhibitors of the enzymatic activity of psa, intermediates, process for their preparation and pharmaceutical compositions thereof
NZ313606A (en) Benzo[g]quinoline derivatives and pharmaceutical compositions thereof for treating depression, anxiety and bipolar disorders
AU2675095A (en) Indol derivatives useful for the treatment of migraine, composition and utilization
HUP9901359A3 (en) Azetidinone derivatives for the treatment of atherosclerosis, process for their producing and pharmaceutical compositions containing them
HUP9900947A3 (en) Process for the preparation of piperidine derivatives, intermediates and preparation thereof
HUP9901153A3 (en) Azetidinone derivatives for the treatment of atherosclerosis, their production and pharmaceutical compositions containing them
EP0920419A4 (en) CONNECTIONS, COMPOSITIONS AND METHODS FOR TREATING FLU
ATE207076T1 (de) Ara-c derivate
NO20001288D0 (no) Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmÕte for fremstilling derav og anvendelse som legemiddel
NO992003D0 (no) Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer
NO992110L (no) Syntese av benzo[f]kinoliner
NO974155L (no) Ny fremgangsmåte for fremstilling av 2,3-dihydrobenzofuranolderivater
AU1829195A (en) Energy formulation
NO992006L (no) Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer
HUP9900739A3 (en) Process for the preparation of quinoline derivatives, and the intermediates
DK0937057T3 (da) Hidtil ukendte (-)-enantiomerer af cis-3,4-chromanderivater anvendelige i forebyggelse eller behandling af østrogenrelaterede sygdomme eller syndromer
HUP0105049A3 (en) Novel derivatives from the class of oleandomycin, process for their preparation and their intermediates
BR9911356A (pt) Sìntese de benzo[f]quinolinonas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application